Reviews


TELOMERASE: A NOVEL TARGET OF ANTITUMOR AGENTS

Ru-gang Zhang, Jin-hui Yuan, Xing-wang Wang, Bin Xu, Hong Xie

Abstract

Telomerase activity was found to be high in various human cancers, but absent in most normal tissues. Its expression pattern made it a novel target for antitumor agents. Several strategies against telomerase were presented in this review. Targeting the telomerase RNA component by oligonucleotide/ribozyme was considered to be one of the most hopeful approaches. Some progresses were made in this area, such as the use of PANs and 2-5A antiseuse compounds. The relationships among telomerase activity and cell differentiation, signal trausduction, oncogene, tumor suppressor gene as well as cell cycle modulation also provided a series of valuable ideas in designing anti-telomerase drugs for cancer therapy. In conclusion, although there is still a long way in understanding the mechanism and regulation of telomerase, the advance of studies on telomerase has allowed the development of numerous strategies for the treatment of cancer.